Development of Chronic Heart Failure Model Caused by Inflammatory Cytokines and Establishment of Prophylactic and Therapeutic Strategies for the Heart Failure

炎症细胞因子所致慢性心力衰竭模型的建立及心力衰竭防治策略的建立

基本信息

  • 批准号:
    08557050
  • 负责人:
  • 金额:
    $ 4.48万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1998
  • 项目状态:
    已结题

项目摘要

(1)We have developed a canine model of sustained myocardial dysfunction, in which interleukin-1beta (lL-1beta) bound to microspeheres (MS) was selectively injected into the left main coronary artery. This novel model is unique as the long-term effect of an inflammatory cytokine on the heart can be examined without causing its systemic effect. In this model, sustained left ventricular (LV) dysfunction was noted in animals that received IL-1beta-MS but not in those that received MS alone.(2)First, the role of adhesion molecules was examined. When the adhesion molecule inhibitor, SLeX-oligosaccharide (SLeX-OS), or the P-selectin inhibitor, PB1.3, was pre-administered, the leukocyte infiltration and sustained LV dysfunction caused by IL-1beta were markedly inhibited, indicating the important role of adhesion molecules in this model.(3)Second, the role of nitric oxide (NO) derived from inducible NO synthase (iNOS) was examined. When the non-specific protein synthase inhibitor, dexamethasone … More (DEX), or the iNOS inhibitor, aminoguanidine (AG), was pre-administered, the IL-beta-induced sustained myocardial dysfunction was markedly prevented, indicating the important role of iNOS-derived NO in the pathogenesis of the myocardial dysfunction in this model.(4)Third, the role of superoxide anion was examined. When the superoxide anion synthesis inhibitor, OPC-6535, was pre-administered, the IL-1beta-induced sustained myocardial dysfunction was markedly prevented, indicating that superoxide anion may also play an important role in our model.(5)Finally, we measured the myocardial concentrations of nitrotyrosine as a marker for peroxynitrite production as a result of the interaction between NO and superoxide anion. Superoxide anion is known to be a more cytotoxic factor than NO or superoxide anion. The results showed that nitrotyrosine formation was increased in the IL-beta group, whereas the formation was markedly inhibited in the SLeX-OS, PB 1.3, DEX, AG, and OPC-6535 groups. There was a significant correlation between he myocardial concentrations of nitrotyrosine and LV dysfunction, indicating that peroxynitrite is at least one of the major causative factors for the myocardial dysfunction in our model in vivo. Less
(1)We已经开发了一种持续心肌功能障碍的犬模型,其中将与微球(MS)结合的白细胞介素-1 β(IL-1 β)选择性地注射到左主冠状动脉中。这种新的模型是独特的,因为可以检查炎性细胞因子对心脏的长期影响,而不会引起其全身效应。在该模型中,在接受IL-1 β-MS的动物中观察到持续的左心室(LV)功能障碍,但在仅接受MS的动物中未观察到。(2)首先,研究粘附分子的作用。当预先给予粘附分子抑制剂SLeX-寡糖(SLeX-OS)或P-选择素抑制剂PB1.3时,由IL-1 β引起的白细胞浸润和持续的LV功能障碍被显著抑制,表明粘附分子在该模型中的重要作用。(3)诱导型一氧化氮合酶(inducible NO synthase,iNOS)所产生的一氧化氮(nitric oxide,NO)的作用。当非特异性蛋白合成酶抑制剂地塞米松 ...更多信息 (DEX)或预先给予iNOS抑制剂氨基胍(AG),可明显预防IL-β诱导的持续性心肌功能障碍,提示iNOS源性NO在该模型心肌功能障碍的发病机制中起重要作用。(4)研究了超氧阴离子的作用。当预先给予超氧阴离子合成抑制剂OPC-6535时,IL-1 β诱导的持续性心肌功能不全被显著预防,表明超氧阴离子在我们的模型中也可能发挥重要作用。(5)最后,我们测定了心肌中硝基酪氨酸的浓度,作为NO与超氧阴离子相互作用产生过氧亚硝酸盐的标志物。超氧阴离子是一种比NO或超氧阴离子更具细胞毒性的因子。结果显示,IL-β组中硝基酪氨酸形成增加,而SLeX-OS、PB 1.3、DEX、AG和OPC-6535组中硝基酪氨酸形成显著抑制。心肌硝基酪氨酸浓度与左室功能障碍之间存在显著相关性,表明过氧亚硝酸盐至少是我们体内模型中心肌功能障碍的主要致病因素之一。少

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shimokawa H et al.: "Cytokine generation capacities of monocytes are reducedin patients with severe heart failure." American Heart Journal. 136. 991-1002 (1998)
Shimokawa H 等人:“严重心力衰竭患者的单核细胞的细胞因子生成能力降低。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shimokawa H: "Acute myocardial infarction and cytokines." Journal of Immunology and Immuno-Pharmacology. 18. 30-34 (1998)
Shimokawa H:“急性心肌梗死和细胞因子。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shimokawa H et al.: "Chronic treatment with interleukin-1β induces coronary intimal lesions and……" Journal of Clinical Investigation. 97. 769-776 (1996)
Shimokawa H 等人:“用白细胞介素 1β 进行慢性治疗会引起冠状动脉内膜损伤并……”《临床研究杂志》97. 769-776 (1996)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shimokawa H,et al.: "Chronic treatment with interleukin-1 β induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derivedgrowth factor." Journal of Clinical Investigation. 97. 769-776 (1996)
Shimokawa H 等人:“白细胞介素 1 β 的长期治疗会诱导猪体内冠状动脉内膜损伤和血管痉挛反应。血小板衍生生长因子的作用。临床研究杂志 97. 769-776 (1996)”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shimokawa H: "Endothelial dysfunction in hypertension." Journal of Atherosclerosis and Thrombosis.4. 118-127 (1998)
Shimokawa H:“高血压的内皮功能障碍。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIMOKAWA Hiroaki其他文献

SHIMOKAWA Hiroaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIMOKAWA Hiroaki', 18)}}的其他基金

The possibility of pleiotropic effects of Novel Oral Anticoagulants (NOAC) on Rho-kinase-cyclophilin A System
新型口服抗凝剂 (NOAC) 对 Rho-激酶-亲环素 A 系统多效作用的可能性
  • 批准号:
    25670379
  • 财政年份:
    2013
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The role of SmgGDS in the pleiotropic effects by statins
SmgGDS 在他汀类药物多效性中的作用
  • 批准号:
    23659071
  • 财政年份:
    2011
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular mechanisms for NOSs-mediated responses in microvessels
NOS介导的微血管反应的分子机制
  • 批准号:
    22390154
  • 财政年份:
    2010
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Experimental and Clinical Studies on the Significance of Endothelium-Derived Hyperpolarizing Factor (EDHF)
内皮源性超极化因子(EDHF)意义的实验和临床研究
  • 批准号:
    16209027
  • 财政年份:
    2004
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
International Collaboration Study on the Racial Difference in Coronary Vasospasm
冠状动脉痉挛种族差异的国际合作研究
  • 批准号:
    15256003
  • 财政年份:
    2003
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of Nanomedicine for the Treatment of Cardiovascular Diseases
开发治疗心血管疾病的纳米药物
  • 批准号:
    13557068
  • 财政年份:
    2001
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of Rho/Rho-kinase-mediated pathway in the pathogenesls of atherosclerosis
Rho/Rho激酶介导的通路在动脉粥样硬化发病机制中的作用
  • 批准号:
    13307024
  • 财政年份:
    2001
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Basic and clinical studies on the role of inflammatory mechanisms in the pathogenesis ischemic heart disease
炎症机制在缺血性心脏病发病机制中的基础与临床研究
  • 批准号:
    12470158
  • 财政年份:
    2000
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The role of inflammatory mechanisms in the pathogenesis of ischemic heart disease. Basic and clinical studies.
炎症机制在缺血性心脏病发病机制中的作用。
  • 批准号:
    07457173
  • 财政年份:
    1995
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of Inflammatory Cytokines in the Development and Progression of Ischemic Heart Diseases-Experimental and Clinical Studies-
炎症细胞因子在缺血性心脏病发生和进展中的作用-实验和临床研究-
  • 批准号:
    05454274
  • 财政年份:
    1993
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
  • 批准号:
    2321481
  • 财政年份:
    2024
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
  • 批准号:
    2321480
  • 财政年份:
    2024
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Continuing Grant
Non-Canonical Roles for Cell-Adhesion Molecules in Presynaptic Assembly
细胞粘附分子在突触前组装中的非典型作用
  • 批准号:
    10751904
  • 财政年份:
    2023
  • 资助金额:
    $ 4.48万
  • 项目类别:
Mechanisms underlying the roles of cell adhesion molecules in the circadian timing system
细胞粘附分子在昼夜节律系统中的作用机制
  • 批准号:
    RGPIN-2020-05262
  • 财政年份:
    2022
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Discovery Grants Program - Individual
Molecular coordination of adhesion molecules in foraging behaviors and circuits
觅食行为和回路中粘附分子的分子协调
  • 批准号:
    10674883
  • 财政年份:
    2022
  • 资助金额:
    $ 4.48万
  • 项目类别:
Mechanisms underlying the roles of cell adhesion molecules in the circadian timing system
细胞粘附分子在昼夜节律系统中的作用机制
  • 批准号:
    RGPIN-2020-05262
  • 财政年份:
    2021
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Discovery Grants Program - Individual
The role of cadherin cell adhesion molecules in postnatal porcine islet cell function.
钙粘蛋白细胞粘附分子在出生后猪胰岛细胞功能中的作用。
  • 批准号:
    449549
  • 财政年份:
    2020
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Studentship Programs
Establishment of novel diagnosis based on expression pattern and functional analysis of rare intercellular adhesion molecules in ocular surface malignancies
基于眼表恶性肿瘤中罕见细胞间粘附分子的表达模式和功能分析建立新的诊断
  • 批准号:
    20K16337
  • 财政年份:
    2020
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Role of insect olfactory receptors and cell adhesion molecules in circuit organization
昆虫嗅觉受体和细胞粘附分子在电路组织中的作用
  • 批准号:
    2006471
  • 财政年份:
    2020
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Continuing Grant
Elucidation of epithelial-connective tissue interactions mediated by cell adhesion molecules in drug-induced gingival hyperplasia
阐明药物诱导的牙龈增生中细胞粘附分子介导的上皮-结缔组织相互作用
  • 批准号:
    20K23026
  • 财政年份:
    2020
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了